<p>Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study</p>
202043 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 1.84
<p>Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study</p> | Researchclopedia